Prestige Q1 earnings beat forecasts
Prestige Consumer Healthcare posted 6.5% Q1 revenue growth and robust free cash flow of $70.8 million, raising its fiscal 2027 outlook to include recent acquisitions.
View filing at SEC.gov →4 most recent filings and news items mentioning PBH. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/PBH/news?limit=20"
Pull PBH filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayPrestige Consumer Healthcare posted 6.5% Q1 revenue growth and robust free cash flow of $70.8 million, raising its fiscal 2027 outlook to include recent acquisitions.
View filing at SEC.gov →Prestige Brands filed an indenture to issue 6.250% Senior Notes due 2034 dated July 15, 2026. This formal step initiates the documentation for a future debt issuance transaction.
View filing at SEC.gov →Prestige intends to issue up to $400 million in new senior notes due 2034 to redeem its outstanding 2028 notes. This transaction extends the company's debt maturity profile as current borrowing costs improve.
View filing at SEC.gov →Prestige Consumer Healthcare closed its acquisition of the Breathe Right nasal strip brand and other brands from Foundation Consumer Healthcare for $1.045 billion, financed through cash and a new Term Loan B. The iconic #1 nasal strip brand becomes Prestige's largest brand and ma
View filing at SEC.gov →